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Objectives: To assess body composition in women with fibromyalgia (FM) comparing to the 
reference value for healthy women. 
Patients and Methods: Cross-sectional observational analytical study, with 52 women se-
lected with Fibromyalgia, according American College of Rheumatology (ACR, 1990) criteria. 
The patients were selected in Hospital de Clínicas da Universidade Federal do Paraná (HC-
UFPR) and divided into two groups, 28 patients with a BMI (Body Mass Index) equal or 
higher (≥) than 25 kg/m2 and 24 patients with BMI less or equal (≤) 24.99 kg/m2, subjected 
to physical examination for the count of tender points (TP) and completing the fibromyalgia 
impact questionnaire (FIQ). The assessment of body composition was performed by the 
Dual-Energy X-Ray Absorptiometry (DXA). The values of the fat mass percentage (MG %) 
found in the two groups were compared to the average percentage of MG by age and sex, 
described by Heward (2004). 
Results: The mean age of the study groups was 47.8 ± 8.6 years, the FIQ score was 70.5 ± 18.6 
and TP 16.2 ± 2.0. The mean BMI was 26.4 ± 4.1 kg/m2, and the amount of MG was 25.2 ± 7.8 
kg and 39.5 ± 6.8%, and lean mass (LM) was 37 2 ± 3.7 kg and 60.4 ± 7.3%. In the group with 
BMI ≤ 25 kg/m2, the MG % was 33.8% (21.5 - 42.4) and in the group with BMI ≥ 25 kg/m2 of 
the MG was 44.4% (37.6 - 56.2). 
Conclusion: Both groups women with FM eutrophic as the overweight and obese group, pre-
sented higher reference MG% levels comparing with the standard levels for healthy women.
© 2014 Sociedade Brasileira de Reumatologia. Published by Elsevier Editora Ltda. 
All rights reserved.
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Composição corporal por absorciometria radiológica de dupla energia de 
mulheres com fibromialgia
Palavras-chave:
Fibromialgia
Composição corporal
Massa gorda
DXA
r e s u m o
Objetivos: Avaliar a composição corporal de mulheres com fibromialgia (FM) em relação ao 
valor de referência para mulheres saudáveis. 
Pacientes e Métodos: Estudo transversal observacional, composto por 52 mulheres diagnos-
ticadas com fibromialgia conforme os critérios do American College of Rheumatology (ACR, 
1990), selecionadas no Ambulatório de Fibromialgia do Hospital de Clínicas da Universida-
de Federal do Paraná (HC-UFPR). As pacientes voluntárias foram divididas em dois grupos, 
28 pacientes com Índice de Massa Corporal (IMC) igual ou superior (≥) a 25 kg/m2, e 24 
pacientes com IMC igual ou inferior (≤) a 24,99 kg/m2 e submetidas ao exame físico para a 
contagem dos tender points (TP), além de preencherem o questionário de impacto da fibro-
mialgia (FIQ). A avaliação da composição corporal foi realizada por meio da Absorciometria 
Radiológica de Dupla Energia (DXA). Os valores do percentual de massa gorda (% de MG), 
encontrados nos dois grupos, foram comparados ao percentual médio de MG por idade e 
sexo, descrito por Heward (2004). 
Resultados: A idade média dos grupos pesquisados foi de 47,8 ± 8,6 anos, o score do FIQ foi 
de 70,5 ± 18,6 e TP 16,2 ± 2,0. O IMC médio foi de 26,4 ± 4,1 kg/m2, e a quantidade de MG foi 
de 25,2 ± 7,8 kg ou 39,5% ± 6,8%, e de massa magra (MM) foi de 37,2 ± 3,7 kg ou 60,4% ± 7,3%. 
No grupo com IMC ≤ 25 kg/m2 o percentual de MG foi de 33,8% (21,5 – 42,4), e no grupo com 
IMC ≥ 25 kg/m2 o percentual de MG foi de 44,4% (37,6 – 56,2). 
Conclusão: Tanto mulheres com FM eutróficas quanto as com sobrepeso e obesas apresenta-
ram percentual de MG acima dos valores de referência de mulheres saudáveis.
© 2014 Sociedade Brasileira de Reumatologia. Publicado por Elsevier Editora Ltda. 
Todos os direitos reservados.
Introduction
Fibromyalgia (FM) is a chronic clinical syndrome of unknown 
aetiology, characterized by a diffuse widespread muscle pain, 
fatigue and non-restorative sleep with physical and psycho-
logical damage to their carriers.1 In 1990, the American Col-
lege of Rheumatology (ACR) established classification criteria 
for fibromyalgia, characterized by a widespread pain in at 
least three of the four established quadrants and that persists 
for a period of three months, and pain to palpation in 11 of 
the 18 tender points previously determined.2
FM affects approximately eight times more women than 
men, especially in the age group between 35 and 60 years, 
causing a negative impact on quality of life and on daily ac-
tivities of these individuals.3,4
Studies have shown a higher prevalence of overweight and 
obesity in this population, when compared to general popula-
tion, and it has been observed a marked worsening of pain 
sensitivity and, therefore, of quality of life and the ability to 
perform physical activities.5,6
Another possible mechanism to explain the link between 
obesity and FM is the psychological factor, given that the dis-
ease is strongly associated with depression and eating disor-
ders, which may result in changes in body weight, especially 
among women with low levels of physical activity.7,8
It is not possible to assert the role that obesity plays in 
the pathophysiology of the disease, whether it would be cause 
or consequence, or if, in addition to excess weight, the body 
composition are changed. 
In this context, an accurate assessment of the nutrition-
al status becomes relevant. BMI is a widely used method by 
health professionals for this purpose, but it is limited and 
does not provide information on the distribution and amount 
of body fat. Sometimes, individuals classified as normal by 
BMI may have excess body fat.9,10
The body composition quantifies the body parts, and its 
determination is important for understanding the effects that 
diet, exercise, disease and physical growth, among other envi-
ronmental factors, have on the human body.11 But it is impor-
tant that, in addition to body weight and BMI, body composi-
tion in patients with FM be also evaluated.
The identification of the body measures of fat mass (FMass) 
and lean mass (LMass) can be accomplished by several meth-
ods, including dual energy X-ray absorptiometry (DXA), consid-
ered an indirect reference method for the estimation of body 
components and the nutritional status of individuals from 
various age groups. DXA offers, as advantage, a good precision, 
accuracy and reproducibility, being based on the measurement 
of three body parts (bone mineral tissue, FMass and LMass), 
and generating data both for total body analysis as for specific 
body segments: upper limbs, lower limbs and trunk.13-16
So far, few studies have been published exploring the body 
composition in women with FM. It is important to understand 
whether there are differences in body composition of these 
women, compared to reference values for healthy women, to 
guide the nutritional planning, in view to provide greater food 
and nutritional safety to this group.
Taking into account the consequences of obesity in relation 
to FM, and the possible relationship of body composition to a 
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worsening of symptoms and quality of life of patients, the aim 
of this study was to evaluate the body composition in women 
with FM compared to the reference value for healthy women.
Patients and methods 
Study design
This is an observational cross-sectional analytical study, ap-
proved by the Research Ethics Committee, Hospital de Clíni-
cas, Universidade Federal do Paraná (HC/UFPR), according to 
decision 8786. 
All patients who agreed to participate signed an informed 
consent (IC).
The study included female patients aged 18-60 years, 
selected at the Clinic of Rheumatology, HC/UFPR, between 
March and October 2012, diagnosed with FM according to 1990 
ACR criteria.2
Patients with infectious diseases, those who modified their 
medication in the four weeks preceding the survey, who used 
corticosteroids, with diabetes, uncompensated endocrine 
diseases (such as hypothyroidism), severe cardiovascular dis-
ease, malignancy in the last year, severe psychiatric illness 
(substance abuse, schizophrenia, psychosis), and pregnant 
and lactating women were excluded from the study. 
The 52 selected patients were evaluated for impact of FM 
on their quality of life, number of tender points, anthropo-
metrics, and body composition. 
To assess the impact of FM on patients’ quality of life, we 
applied the fibromyalgia impact questionnaire (FIQ), which 
contains questions related to functional ability, professional 
activity, psychological distress and physical symptoms which, 
at the end, feature a score ranging from 0 to 100, depending 
on the severity of symptoms, with 100 being the maximum 
impact.17
The tender points (TP) were evaluated by the physician, 
according to 1990 ACR criteria.2 
The height was measured in centimeters (cm) and con-
verted to meters (m), in a wall stadiometer, to the nearest 0.1 
cm. To obtain the body weight in kilograms (kg), a portable 
digital scale with a capacity of 150 kg was used.18 
BMI was obtained by the ratio of weight in kilograms by 
the height squared in meters: BMI = weight (kg)/height (m)2 
and was classified as: underweight, <18.5 kg/m2; eutrophic, 
between 18.5 and 24.99 kg/m2; overweight, between 25 and 
29.99 kg/m2; and obesity >30 kg/m2.9
Determination of body composition 
The assessment of body composition was performed by dual 
energy X-ray absorptiometry (DXA) using a Lunar Prodigy Ad-
vance DPX equipment, with the patient lying supine with legs 
and arms straight and flush with the unadorned body.12,19,20 
The examination was conducted by a specialized technician.
The results were issued with the aid of software Encore 
version 12.10. Values of FMass and LMass described in grams 
and converted to kilogram (kg) and FMass% were obtained. 
The mean values of FMass% and age for the two groups stud-
ied were calculated and compared to the reference values of 
choice, which determine that the mean FMass% for women 
of age 34-55 years is 32%.21 The FMass values found in the 
evaluation of women with fibromyalgia were compared with 
reference values for healthy women. Then the percentage dif-
ference between the findings for our two groups, which we 
define as the percentage of adequacy, was calculated.
Statistical analysis
For the statistical analysis, the Student’s t-test with R soft-
ware (R Development Core Team, 2013), and Microsoft® Ex-
cel 2010 was performed. We considered a significance level of 
95% (p ≤0.05).
Results
The mean age of the women studied was 47.8±8.6 years, and 
the length of disease reported was 7.2±4.9 years (Table 1). 
The FIQ score was 70.5±18.6, and the number of tender 
points was 16.2 ± 2.0. An increased of the severity of symp-
toms by FIQ, arbitrarily determined as greater than 70, was 
observed in 33 (63.5%) patients (Table 1). 
The occupation of the patients presented the following 
distribution: 24 (46.1%) as housewives, 25 (48.1%) as having 
a formal activity, and 3 (5.8%) as off work due to FM (Table 1).
In the distribution by BMI, 24 (46.1%) patients were eutro-
phic, 16 (30.8%) were overweight, and 12 patients (23.1%) were 
obese (Table 1). 
The mean BMI of the group was 26.4±4.1 kg/m2, and, by 
checking the body composition, it was observed that the mean 
FMass was 25.2±7.8 kg or 39.5±7.3%; and the mean LMass was 
37.2±3.7 kg or 60.4±7.3%, as described in Table 2. 
In the analysis of groups separated by BMI, when compared 
to the reference value of 32% used for FMass, the FMass% and 
the percentage of adequacy of the group with BMI ≤24.99 kg/
m2 were 33.8% (21.5 - 42.4) and 5.75%, respectively; and for the 
group with BMI ≥25 kg/m2, the values were 44.4% (37.6 - 56.2) 
and 38.85%, respectively, with statistically significant differ-
ences between groups (Table 3).
Discussion
The larger body weight and BMI have been described as dis-
turbing factors in the general population and in groups with 
FM. This study is relevant thanks for the paucity of data in the 
literature to date, and also because, in addition to identify-
ing overweight and BMI, classifies the body composition using 
DXA as a method.
Among the results obtained according to BMI classifica-
tion, we observed that 24 women had normal weight, and 28 
were overweight or obese. Analyzing the BMI of all women, 
the mean value was 26.4 kg/m2 (overweight). 
Several authors who have studied groups with FM use BMI 
to assess the nutritional status of patients, either for the char-
acterization of individuals, and in order to establish correla-
tions between nutritional status, functionality, quality of life 
and symptomatology in disease.22-28
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In general, the specialized literature reveals that in the 
analysis of BMI in women with FM, overweight and obesity 
are frequent, and that the increase in BMI has a negative cor-
relation with quality of life and a positive correlation with 
physical dysfunction and number of tender points. In the 
present study, these correlations were not established. Some 
authors suggest that the weight loss leads to improvement in 
the general condition and quality of life of these patients. 8,29-31
Lowe et al. (2006) report that the possible cause of obesity 
in the group with FM is partly due to the smaller basal energy 
expenditure, despite the level of physical activity and hor-
monal disorders.32 
In the body composition analysis in this study, the mean 
FMass% was 39.5%, which, when compared to the reference 
value for healthy women (32%), was above average. This 
finding confirms that the FMass% from women with FM is 
consistent with the values for obese women.21 This finding 
demonstrates that the profile of body composition in wom-
en with FM may be peculiar to the syndrome, and further 
studies are needed to explore the subject.
After splitting the group by BMI and comparing with 
the above mentioned reference value, it was observed that 
the FMass% of the group with BMI ≤24.99 was 5.75% higher 
than the recommended, while in the group with BMI ≥25 
kg/m2, the FMass% was 38.85% above the recommended 
level. These results show that women with FM presented 
a FMass% higher than the recommended, and that over-
weight and obese women have more quantity of adipose 
tissue. 
Based on these results, it can be inferred that women 
with FM, regardless of body weight and BMI, present a 
FMass amount above the recommended values. This finding 
demonstrates that, in addition to the impairment in quality 
of life and functionality, and to a worsening of symptoms of 
the disease, in these patients there is an increased risk for 
the onset of chronic non-communicable diseases (CNCDs).
In the study of Arranz et al. (2012), with 103 women 
with FM in which the relationship between body composi-
tion and quality of life was evaluated, it was observed that 
patients with higher fat mass showed worsening of their 
general health, as well as in the emotional status and pain 
sensation. These authors suggest that the amount of FMass 
may be associated with increased severity of fibromyal-
gia symptoms, lower levels of quality of life, worsening of 
physical fitness and a higher number of tender points.31
In Spain, in a study on the analysis of body composition 
in women with FM measured with bioelectric impedance, 
the authors found a mean value for total body FMass of 28.3 
kg (38.6%), and concluded that obesity is a common condi-
tion among women with FM, with a prevalence of 33.7%.6 
More studies are needed in the analysis of body com-
position in patients with FM, in order to generate further 
information on the prevalence of overweight and obesity in 
this group, and the effect of body fat on disease symptoms 
and its interference in quality of life.
Table 1 – Demographic and clinical variables of patients 
with fibromyalgia
VARIABLES FM Women
n=52
%
Age (years) 47.8±8.6* -
Length of illness (years) 7.2±4.9* -
FIQ score 70.5±18.6* -
Tender points (TP) 16.2±2.0* -
Severity of symptoms
(FIQ ≥70)
33 63.5
BMI (kg/m2)
Underweight (<18.5)
Normal weight (18.5 - 24.99)
Overweight (25.0 - 29.99) 
Obesity (>30) 
0
24
16
13
-
46.1
30.8
23.1
Schooling
Fundamental Education 1
Fundamental Education 2
High School
Graduate/Postgraduate
10
14
19
9
19.2
26.9
36.6
17.3
Occupation
Housewife
Formal worker
Student
Off work
24
25
0
3
46.1
48.1
0
5.8
Income
Up to 2 MW
2-5 MW
Over 5 MW
17
19
16
32.7
36.5
30.8
FIQ: Fibromyalgia impact questionnaire; MW: Minimum wage; 
*Mean and standard deviation values; %: Values are represented as 
a percentage.
Table 2 – Anthropometrics and body composition data of 
women with fibromyalgia
VARIABLES n=52
MEAN (SD)
MINIMUM /  
MAXIMUM
Height (m) 1.57 (0.10) 1.43 / 1.69
Weight (kg) 65.5 (10.2) 45.12 / 92.6
BMI (kg/m2) 26.4 (4.1) 18.9 / 34.9
Fat mass (kg)
Fat mass (%)
25.2 (7.8)
39.5 (7.3)
9.79 / 39.92
21.5 / 56.2
Lean mass (kg)
Lean mass (%)
37.2 (3.7)
60.4 (7.3)
29.08 / 51.49
43.8 / 78.5
Data are expressed as mean; and SD: Standard Deviation. Values: 
Minimum and maximum; m: meter; and %: percentage.
Table 3 – Percentage of FM of women with fibromyalgia 
with BMI ≤24.99 kg/m2 and BMI ≥25 kg/m2, with 
reference values
Groups/
Variables
FM (%)
(mean)
(min-max)
Reference 
FM (%) 
Adequacy
%
BMI ≤24,99
(kg/m2)
 
BMI ≥25
(kg/m2)
33.8
(21.5 - 42.4)
44.4
(37.6 - 56.2)
32
32
5.75
38.85
P-value 0.000* - -
BMI: Body mass index; FM: Fat mass; kg: kilogram; m: meter; and 
%: percentage 
Data are expressed as mean, minimum and maximum. *Significant 
difference (p <0.005) 
Reference value: adapted by Heward, 2004.
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Though we have considered the reference values of FMass 
for healthy women without regard to race and geographic re-
gion, our data point to the need for individualized food and 
nutrition planning, giving consideration to body composition.
Conclusion
The quantification of FMass in patients with FM is relevant 
because, apart from being an integral part of the global nu-
tritional assessment, the adipose tissue has been considered 
as an important component in the pathophysiology of this 
disease. However, the elements and mechanisms of adipose 
tissue need to be clarified. 
In the analysis of body composition of women with FM 
classified according to BMI as normal weight, overweight and 
obese, it was observed that the percentage of FMass is above 
the reference values for healthy women. These data indicate 
the need for using methods to assess body composition and 
not only the total body mass.
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